scispace - formally typeset
T

Tamas Szakmany

Researcher at Cardiff University

Publications -  159
Citations -  4344

Tamas Szakmany is an academic researcher from Cardiff University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 26, co-authored 118 publications receiving 2348 citations. Previous affiliations of Tamas Szakmany include Aneurin Bevan University Health Board & University of Pécs.

Papers
More filters
Journal ArticleDOI

Effectiveness of a national quality improvement programme to improve survival after emergency abdominal surgery (EPOCH): a stepped-wedge cluster-randomised trial

Carol J. Peden, +560 more
- 01 Jun 2019 - 
TL;DR: No survival benefit was observed from this QI programme to implement a care pathway for patients undergoing emergency abdominal surgery, and future QI programmes should ensure that teams have both the time and resources needed to improve patient care.
Journal ArticleDOI

Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK.

Chloe I Bloom, +339 more
- 04 Mar 2021 - 
TL;DR: In this paper, the effect of inhaled corticosteroid use in patients admitted to hospital with COVID-19 with underlying respiratory conditions was examined. But, the results were limited to patients aged 50 years and older and not for those with chronic pulmonary disease.
Journal ArticleDOI

Hemodynamic and respiratory changes during lung recruitment and descending optimal positive end-expiratory pressure titration in patients with acute respiratory distress syndrome.

Ildikó Y. Tóth, +5 more
- 01 Mar 2007 - 
TL;DR: Following lung recruitment and descending optimal PEEP titration, the Pao2 improves significantly, without any change in theEVLW up to 1 hr, which suggests a decrease in atelectasis as a result of recruitment rather than a reduction of EVLW.
Journal ArticleDOI

Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study.

Thomas M Drake, +378 more
- 17 Jul 2021 - 
TL;DR: In this paper, the authors used multilevel logistic regression and survival models to explore associations between these outcomes and in-hospital complications, age, and pre-existing comorbidities.
Journal ArticleDOI

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

Obbina Abani, +7885 more
- 03 Mar 2022 - 
TL;DR: In patients hospitalised with COVID-19, baricitinib significantly reduced the risk of death but the size of benefit was somewhat smaller than that suggested by previous trials.